The dissolution and solid-state behaviours of coground ibuprofen-glucosamine HCl

Drug Development and Industrial Pharmacy

Volumn 41, Issue 10, 2014, Pages 1520-1562

  Al Hamidi, Hiba ^a   Asare Addo, Kofi ^b   Desai, Sandip ^a   Kitson, Mike ^a   Nokhodchi, Ali ^c,d  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cogrinding; Dissolution enhancement; Glucosamine HCl; Solid state; Solubility

Indexed keywords

CARBAMAZEPINE; CARBOXYLIC ACID; GLUCOSAMINE; HYDROXYL GROUP; IBUPROFEN;

ACIDITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTAL STRUCTURE; DISPERSION; DISSOLUTION; DRUG ADSORPTION; DRUG EFFICACY; DRUG SOLUBILITY; DRUG STRUCTURE; ENTHALPY; ESTERIFICATION; GRINDING; HYDROGEN BOND; HYDROPHILICITY; MELTING POINT; MOLECULAR WEIGHT; PARTICLE SIZE; SOLID STATE; SURFACE PROPERTY; TIME; WETTABILITY; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DOSE RESPONSE; DRUG RELEASE; INFRARED SPECTROSCOPY; PH; PHARMACEUTICS; PROCEDURES; SOLUBILITY; TIME FACTOR; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG LIBERATION; GLUCOSAMINE; HYDROGEN-ION CONCENTRATION; IBUPROFEN; PARTICLE SIZE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; X-RAY DIFFRACTION;

EID: 84925368809     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.991401     Document Type: Article

References (30)

1. Otsuka M, Kaneniwa N. Effects of grinding on the physicochemical properties of cephalexin. Chem Pharm Bull 1984;32:1071-9.
2. Ford JL. The current status of solid dispersions. Pharm Acta Helv 1986;61:69-88.
3. Takeuchi H, Handa T, Kawashima Y. Enhancement of the dissolution rate of a poorly watersoluble drug (tolbutamide) by a spraydrying solvent deposition method and disintegrants. J Pharm Pharmacol 1987;39:769-73.
4. Nyström C, Westerberg M. The use of ordered mixtures for improving the dissolution rate of low solubility compounds. J Pharm Pharmacol 1986;38:161-5.
5. Nozawa Y, Suzuki K, Miyagishima A, Hirota S. Solid-phase complexing of ibuprofen to b-cyclodextrin by roll mixing. Powder Tech 1994;79:269-71.
6. Moyano JR, Gines JM, Arias MJ, Rabasco AM. Study of the dissolution characteristics of oxazepam via complexation with betacyclodextrin. Int J Pharm 1995;114:95-102.
7. Buckton G, Beezer AE. The relationship between particle-size and solubility. Int J Pharm 1991;82:R7-10.
8. Martini A, Torricelli C, Deponti R. Physico-pharmaceutical characteristics of steroid cross-linked polyvinylpyrrolidone coground systems. Int J Pharm 1991;75:141-6.
9. Yamaguchi G, Sakamoto K. Effect of dry grinding on gibbsite B. Chem Soc Jpn 1959;32:1364-8.
10. Mochalin VN, Sagar A, Gour S, Gogotsi Y. Manufacturing nanosized fenofibrate by salt assisted milling. Pharm Res 2009;26: 1365-70.
11. 3(001): molecular-dynamics simulations. Phys Rev B 1997;56:13535-42.
12. Liversidge G, Cundy K. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 1995; 125:91-7.
13. Sugimoto M, Okagaki T, Narisawa S, et al. Improvement of dissolution characteristics and bioavailability of poorly watersoluble drugs by novel cogrinding method using water-soluble polymer. Int J Pharm 1998;160:11-19.
14. Yamada H, Takahashi S, Fujita H, et al. Cytokine-induced neutrophil chemoattractants in healing of gastric ulcers in rat - expression of 4 40-kDa chemo-attractant in delayed ulcer healing by indomethacin. Dig Dis Sci 1999;44:889-95.
15. Sarkari M, Brown J, Chen XX, et al. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm 2002;243:17-31.
16. Moneghini M, Kikic I, Voinovich D, et al. Processing of carbamazepine PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution. Int J Pharm 2001;222:129-38.
17. Camarada CC, Dowless G. Glucosamine sulfate for osteoarthritis. Ann Pharmaco Ther 1998;832:580-7.
18. Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulfate in the basic treatment of osteoarthrosis. Curr Med Res Opin 1980;7:110-14.
19. Horton D. Monosaccharide amino sugars. In: Jeanloz RW, ed. The amino sugars, the chemistry and biology of compounds containing amino sugars, Vol IA. Academic Press Inc: 1969:4-18.
20. Clegg DO, Jackson CG. Glucosamine. In: Coates PM, ed. Encyclopedia of dietary supplements. USA: Marcel Dekker; 2005:79-87.
21. Al-Hamidi H, Mohammad Amin M, Edwards AA, Nokhodchi A. To enhance dissolution rate of poorly water soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B-Biointerfaces 2010;76:170-8.
22. Al-Hamidi H, Edwards AA, Douroumis D, et al. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling. Colloids Surf B Biointerfaces 2013;103: 189-99.
23. Khan KA. Concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48-9.
24. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The effect of selected water-soluble excipients on the dissolution of paracetamol and Ibuprofen. Drug Dev Ind Pharm 2005;31:515-25.
25. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the standing committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59: 936-44.
26. Atkinson RM, Bedford C, Child KJ, Tomich EG. Effect of particle size on blood griseofulvin-levels in man. Nature 1962;193:588-9.
27. Liversidge GG, Conzentino P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm 1995;125:309-13.
28. Barzegar-Jalali M, Valizadeh H, Dastmalchi S, et al. Enhancing dissolution rate of carbamazepine via cogrinding with Crospovidone and hydroxypropylmethylcellulose. Iran J Pharm Res 2007;6: 159-65.
29. Barzegar-Jalali M, Valizadeh H, Siahi-Shadbad MR, et al. Cogrinding as an approach to enhance dissolution rate of a poorly water soluble drug (gliclazide). Powder Tech 2010;197:150-8.
30. Yonemochi E, Kitahara S, Maeda S, et al. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. Eur J Pharm Sci 1999;7:331-8.